AITRICS is a South Korean medical-AI company aiming to 'predict a patient's sudden deterioration hours ahead, in time.' Its flagship AITRICS-VC (VitalCare) uses AI to analyze 19 kinds of data from electronic health records—6 vital signs, 11 blood tests, level of consciousness, age—and predicts deterioration such as death, cardiac arrest or ICU transfer on a general ward (within 6 hours), sepsis (within 4 hours), and ICU-patient death (within 6 hours). It was the first in Korea to gain approval for predicting sepsis 4 hours ahead. In clinical settings, signs of worsening often appear, yet limited staff cannot watch every patient constantly—it fills that gap so a rapid-response team (RRT) can act first. It is now deployed at over 130 hospitals, has medical-device approval in Malaysia, Indonesia and Hong Kong in addition to Korea's MFDS (a sixth in all), is in the US FDA approval process, and is advancing external validation with the Cleveland Clinic. Its value was especially tested under Korea's 2024–25 healthcare-worker shortage.
●●○ medium
There is no confirmed −; independently verified + decide the position (B). No unreachable strike-through.= non-additive meter
AITRICS: Predicting a patient's sudden deterioration hours ahead, in time. The letter is B; certainty is medium. Unconfirmed concerns are placed under “Watching.” (As of 2026-Q3; estimate based on public information.)
Main narrative
One person’s story (N1)
+ A single story
On wards, even when signs of worsening appeared, limited staff could not watch every patient constantly, and deterioration tended to be caught late. After adopting VitalCare, a physician at Ajou University Hospital said 'the efficiency and precision of critical care improved significantly, with measurable improvement in patient outcomes and greater trust among frontline staff.' The benefit appears as the collective of inpatients who could be caught hours ahead and receive early intervention (per deploying-hospital physicians).
Source nature: P3 Industry / partner-physician account. Positive effects are not used to offset negatives.
Positive / negative effects
+ effects
- AITRICS-VC (VitalCare) uses AI on 19 kinds of EHR data to predict general-ward death/cardiac arrest/ICU transfer (6h), sepsis (4h) and ICU death (6h) (4-hour sepsis prediction is a Korea first). Deployed at over 130 hospitals, with medical-device approval in Korea's MFDS/Malaysia/Indonesia/Hong Kong, an FDA application pending, and external validation with the Cleveland Clinic. It supports the RRT and enables early intervention.P2 Independent (KBR / KoreaBiomed) / Korea Biomedical Review
− effects (confirmed)
- No confirmed −.
- O
- u
- t
- c
- o
- m
- e
- i
- m
- p
- r
- o
- v
- e
- m
- e
- n
- t
- c
- e
- n
- t
- e
- r
- s
- o
- n
- t
- h
- e
- c
- o
- m
- p
- a
- n
- y
- '
- s
- /
- p
- a
- r
- t
- n
- e
- r
- p
- h
- y
- s
- i
- c
- i
- a
- n
- s
- '
- a
- c
- c
- o
- u
- n
- t
- s
- ,
- w
- i
- t
- h
- n
- o
- e
- s
- t
- a
- b
- l
- i
- s
- h
- e
- d
- i
- n
- d
- e
- p
- e
- n
- d
- e
- n
- t
- R
- C
- T
- o
- f
- m
- o
- r
- t
- a
- l
- i
- t
- y
- r
- e
- d
- u
- c
- t
- i
- o
- n
- a
- t
- t
- r
- i
- b
- u
- t
- a
- b
- l
- e
- t
- o
- A
- I
- T
- R
- I
- C
- S
- a
- l
- o
- n
- e
- ;
- a
- h
- o
- s
- p
- i
- t
- a
- l
- -
- f
- a
- c
- i
- n
- g
- B
- 2
- B
- c
- o
- m
- m
- e
- r
- c
- i
- a
- l
- b
- u
- s
- i
- n
- e
- s
- s
- .
- Strengthening evidence with an independent RCT of mortality reduction; expansion into Southeast Asia/US; integration with clinical-support AI such as V.Doc.
A second look
The plus is patient safety and lifesaving through early prediction of inpatient deterioration (sepsis/cardiac arrest/death) → early intervention (People), with relatively solid backing for commercial tech—live use at over 130 hospitals, medical-device approvals in several countries (safety/efficacy review), and external validation with the Cleveland Clinic. Caveats: 'patient outcomes improved' is assessed mainly from the company's and deploying hospitals' physicians' accounts, there is not yet a large independent RCT showing mortality reduction attributable to AITRICS alone, and it is a hospital-facing B2B commercial business.
Sources
How to read this assessment
- Reachable upper bound (ceiling): a confirmed − sets the ceiling, and independently verified + decide the position within it. + do not cancel out −.
- The weight of evidence is not symmetric: only confirmed − are counted; the volume of disputes or allegations goes under “Watching.” + are counted from independent evidence, while an organization’s own PR is treated as “reference.”
- Size is not value: scale is not used in the assessment. Matters that stay within money or competition—investors, shareholders, sanctions, trade secrets—are also excluded.
- The letter (assessment) and certainty (how reliable the information is) are separate axes.
This is a translation; the Japanese version is authoritative. The assessments here are generated automatically by AI based on published criteria. The operator does not alter individual results. Because they are AI-generated they may contain errors, and they are opinion and commentary, not statements of fact. Where evidence is insufficient, the entry is marked “On hold.” Requests for correction are accepted via the form.
Terms: Narrative Value = an assessment (A–G) of the distance between the story an organization tells and its reality / Ceiling meter = a visualization of the reachable upper bound / Watching = unconfirmed matters not counted / Protected stakeholders = people, animals, nature, and future generations. | Generated by: AI | As of: 2026-Q3 | Back to top